Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases.

Published on Jun 1, 2021in Hypertension7.713
· DOI :10.1161/HYPERTENSIONAHA.120.16752
Chengxin Zhang (Anhui Medical University), Kaiyuan Niu (QMUL: Queen Mary University of London)+ 7 AuthorsZhaolin Chen (USTC: University of Science and Technology of China)
Sources
Abstract
Increasing evidence has suggested that noncoding RNAs (ncRNAs) have vital roles in cardiovascular tissue homeostasis and diseases. As a main subgroup of ncRNAs, long ncRNAs (lncRNAs) have been reported to play important roles in lipid metabolism, inflammation, vascular injury, and angiogenesis. They have also been implicated in many human diseases including atherosclerosis, arterial remodeling, hypertension, myocardial injury, cardiac remodeling, and heart failure. Importantly, it was reported that lncRNAs were dysregulated in the development and progression of cardiovascular diseases (CVDs). A variety of studies have demonstrated that lncRNAs could influence gene expression at transcription, post-transcription, translation, and post-translation level. Particularly, emerging evidence has confirmed that the crosstalk among lncRNAs, mRNA, and miRNAs is an important underlying regulatory mechanism of lncRNAs. Nevertheless, the biological functions and molecular mechanisms of lncRNAs in CVDs have not been fully explored yet. In this review, we will comprehensively summarize the main findings about lncRNAs and CVDs, highlighting the most recent discoveries in the field of lncRNAs and their pathophysiological functions in CVDs, with the aim of dissecting the intrinsic association between lncRNAs and common risk factors of CVDs including hypertension, high glucose, and high fat. Finally, the potential of lncRNAs functioning as the biomarkers, therapeutic targets, as well as specific diagnostic and prognostic indicators of CVDs will be discussed in this review.
📖 Papers frequently viewed together
27 Citations
30 Citations
2 Citations
References107
Newest
#1Ding Ding (Fudan University)H-Index: 51
#2Fen Zhou (Fudan University)H-Index: 1
Last. Wei Deng (Fudan University)H-Index: 3
view all 8 authors...
BACKGROUND the association between cholesterol profiles and risk of cognitive decline among older adults was inconclusive. OBJECTIVE to examine the association between cholesterol profiles and risk of cognitive decline in older adults with or without vascular risk factors (VRFs) in the prospective phase of the Shanghai Aging Study. DESIGN a prospective community-based cohort study. SETTING Shanghai, China. PARTICIPANTS we prospectively followed 1,556 dementia-free participants aged ≥60 years wit...
Source
#1Salim S. ViraniH-Index: 62
#2Alvaro AlonsoH-Index: 94
Last. Connie W. TsaoH-Index: 25
view all 39 authors...
Background The American Heart Association, in conjunction with the National Institutes of Health, annually reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular risk factors, including core health behaviors (smoking, physical activity, diet, and weight) and health factors (cholesterol, blood pressure, and glucose control) that contribute to cardiovascular health. The Statistical Update presents the latest data on a range of major clinical heart and circulato...
37 CitationsSource
#1Hao Zhang (GDUT: Guangdong University of Technology)H-Index: 10
#2Bo Liu (GDUT: Guangdong University of Technology)H-Index: 2
Last. Xiaoou Sun (GDUT: Guangdong University of Technology)H-Index: 6
view all 4 authors...
Cardiocerebrovascular disease is a collective term for cardiovascular and cerebrovascular diseases. Because of the complex mechanisms involved in cardiocerebrovascular diseases, limited effective treatments have been developed. With advancements in precision medicine, studies have focused on long noncoding RNAs (lncRNAs) in cerebrovascular diseases. LncRNAs, which are over 200 nucleotides long, regulate gene expression at epigenetic, transcriptional, and post-transcriptional levels. Moreover, ln...
2 CitationsSource
#1Jacob B. Pierce (NU: Northwestern University)H-Index: 3
#2Mark W. Feinberg (Brigham and Women's Hospital)H-Index: 38
Despite major advances in the primary and secondary prevention of atherosclerosis and its risk factors, atherosclerotic cardiovascular disease remains a major clinical and financial burden on individuals and health systems worldwide. In addition, neointima formation and proliferation due to mechanical trauma to the vessel wall during percutaneous coronary interventions can lead to vascular restenosis and limit the longevity and effectiveness of coronary revascularization. Long noncoding RNAs (ln...
3 CitationsSource
#1Christian Schulte ('KCL': King's College London)H-Index: 8
#2Temo Barwari ('KCL': King's College London)H-Index: 14
Last. Manuel Mayr ('KCL': King's College London)H-Index: 81
view all 5 authors...
The development of more sensitive protein biomarker assays results in continuous improvements in detectability, extending the range of clinical applications to the detection of subclinical cardiovascular disease (CVD). However, these efforts have not yet led to improvements in risk assessment compared with existing risk scores. Noncoding RNAs (ncRNAs) have been assessed as biomarkers, and miRNAs have attracted most attention. More recently, other ncRNA classes have been identified, including lon...
5 CitationsSource
#2Mehmet Demir (UHSA: University of Health Sciences Antigua)H-Index: 8
Cardiovascular diseases are one of the most common causes of death in both developing and developed countries worldwide. Even though there have been improvements in primary prevention, the prevalence of cardiovascular diseases continues to increase in recent years. Hence, it is crucial to both investigate the molecular pathophysiology of cardiovascular diseases in-depth and find novel biomarkers regarding the early and proper prevention and diagnosis of these diseases. MicroRNAs, or miRNAs, are ...
9 CitationsSource
#1Samuel Mabbott (A&M: Texas A&M University)H-Index: 11
#2Syrena C. Fernandes (Tufts University)H-Index: 7
Last. Duncan Graham (University of Strathclyde)H-Index: 64
view all 7 authors...
Detection of miR-29a-3p, a microRNA associated with myocardial infarction, was achieved at a level of pg/L through the combination of three-dimensional paper-based microfluidics, colorimetric detection, and surface enhanced Raman scattering (SERS) analysis. The union of the paper-based device and the two analysis methods resulted in the production of a sensitive, reproducible and facile, point of care test (POCT), which paves the way for future implementation in the diagnosis of a range of dise...
9 CitationsSource
#1Xuexiang Li (Anhui Medical University)H-Index: 1
#2Linlin HouH-Index: 1
Last. Jinglin Cheng (Anhui Medical University)H-Index: 1
view all 6 authors...
OBJECTIVE: The aim of this study is to investigate the clinical value of long noncoding RNA growth arrest-specific transcript 5 (LncRNA GAS5) in the diagnosis of coronary artery disease (CAD) and its protective effect on myocardial injury in rats with CAD. METHODS: Patients with CAD and healthy controls were selected to measure the expression of GAS5, and further to perform the correlation analysis and ROC curve. In addition, the rat models of CAD were also established to observe the effect of G...
15 CitationsSource
#1Laura Santer (MHH: Hannover Medical School)H-Index: 4
#2Begoña López (University of Navarra)H-Index: 54
Last. Javier DíezH-Index: 95
view all 12 authors...
The plasma levels of long noncoding RNA LIPCAR are elevated in heart failure (HF) patients with reduced ejection fraction and associated with left ventricular remodeling and poor outcomes. We studi...
15 CitationsSource
#1Lijuan ZhangH-Index: 1
#2Li WangH-Index: 1
Last. Yuefeng QiH-Index: 1
view all 4 authors...
Abstract Background Cardiac hypertrophy related factor (CHRF), a newly recognized long non-coding RNA (lncRNA), is a central regulator in cardiac hypertrophy responses. This study attempted to show the potential role of lncRNA CHRF in bacterial infection caused myocarditis. Methods H9c2 cells were transfected with small interfering RNAs (siRNAs) specific for lncRNA CHRF alone or in combination with miR-221 inhibitor, and then subjected to lipopolysaccharide (LPS). The following parameters were m...
8 CitationsSource
Cited By0
Newest